Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$2.71 - $4.22 $56,048 - $87,278
20,682 New
20,682 $60,000
Q4 2018

Feb 14, 2019

SELL
$1.15 - $6.45 $664,351 - $3.73 Million
-577,697 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$3.22 - $6.33 $57,666 - $113,363
17,909 Added 3.2%
577,697 $3.57 Million
Q2 2018

Aug 14, 2018

BUY
$5.39 - $8.96 $147,578 - $245,324
27,380 Added 5.14%
559,788 $3.58 Million
Q1 2018

May 15, 2018

SELL
$6.69 - $17.96 $591,168 - $1.59 Million
-88,366 Reduced 14.23%
532,408 $3.71 Million
Q4 2017

Feb 12, 2018

SELL
$10.87 - $13.9 $716,789 - $916,593
-65,942 Reduced 9.6%
620,774 $7.83 Million
Q3 2017

Nov 07, 2017

BUY
$11.86 - $17.34 $8.14 Million - $11.9 Million
686,716
686,716 $8.16 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.04B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.